Navigation Links
Heart disease in women being under-treated

A new study involving 2,763 post menopausal women with heart disease has shown that doctors are under-using aspirin, beta blockers and cholesterol lowering drugs to treat these women even though the medications have been shown to prevent further heart attacks or other heart trouble. Though this study did not look at how often these drugs were offered to men, previous// studies have shown that men and women alike are under-treated for heart disease, and women are treated even less aggressively than men. Dr. Michael Shlipak of the University of California, co-author of the study said that these findings could have many reasons including a lingering myth that heart disease is primarily a man's disease, doctors not using effective prevention methods and also the fear of side effects of preventive drugs in both doctors and patients.

In the study of the 2,763 women, all had suffered heart attacks or chest pain caused by blocked arteries, or had undergone bypass surgery or angioplasty. It was found by the researchers that only one third of these women who should have been taking beta blockers, were taking it and only half the women who qualified for cholesterol-lowering drugs took them. They said that even aspirin, which all of the survivors should have been taking, was taken only by 80 percent.

Dr. Naveed Malik, a cardiologist at the Ochsner Clinic Foundation in New Orleans, who was not connected with the study, said that a woman complaining of chest pain is often detected with heart burn, while similar symptoms in men might prompt doctors to think about coronary artery disease first. In an accompanying editorial, Drs. Andrew Miller and Suzanne Oparil of the University of Alabama added that the research highlighted the terrible discrepancy between what doctors knew about heart disease and how women with the disease were being treated. In conclusion, the article which was published in the Annals of Internal Medicine, said that this study should prove to be a wake-up call to physicians who need to more aggressively use appropriate drugs like aspirin, beta blockers and ACE inhibitors in women with heart disease.


'"/>




Related medicine news :

1. One in Three Heart Attack Patients Have No Chest Pains
2. Epileptic Seizures Can Be Due to Heart Problem
3. Bypass Heart Surgery Performed Without General Anesthesia
4. New CPR Guidelines issued by Heart Association
5. White Cells Count Can Predict Heart Attack Death Risk
6. Vitamins-The answer to Heart Disease?
7. Fight Heart disease and Pain with Meditation
8. Heart disease in the newborn is related to maternal malnutrition
9. New drug to treat Heart Attack and damaged tissue
10. Heart disease threat starts early in life for Diabetics
11. Mechanical Heart
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/23/2017)... VA (PRWEB) , ... June 23, 2017 , ... ... of what is needed and will ultimately do significant harm to people with ... to everyone. , "While it leaves in place the Affordable Care Act ...
(Date:6/23/2017)... ... June 24, 2017 , ... Studies show evidence that carotenoids and ... of visual loss in these patients. , But how often do ophthalmologists and optometrists ... to patients at risk of or with early symptoms of AMD? A study ...
(Date:6/23/2017)... ... 2017 , ... Military Connection friend and veteran advocate Micaela Bensko ... Atlantic lounge. , Bensko is no stranger to the plight of the disabled. ... life to supporting our wounded veterans. A world-class photographer, her riveting photos “The Wounds ...
(Date:6/23/2017)... ... 2017 , ... The Aesthetic Channel has recently highlighted Dr. Ben Talei’s unique ... a proprietary technique that he calls the AuraLyft Facelift. The AuraLyft does ... patients can expect to look refreshed, rejuvenated, and revitalized. , Dr. Talei’s unique ...
(Date:6/23/2017)... ... June 23, 2017 , ... 21 Middle East and South Asia ... 21 leaders from government, business and civil society in 11 countries across the Middle ... fall, engaging in a transformative exchange of knowledge and ideas with the leading minds ...
Breaking Medicine News(10 mins):
(Date:6/8/2017)... 2017  StatLab Medical Products ("StatLab" or ... of diagnostic supplies for the anatomic pathology ... Company LP ("Cressey & Company"), a healthcare-focused ... investment in the Company. Cressey & Company ... selling shareholder, Prairie Capital, L.P., with certain ...
(Date:6/7/2017)... 2017  Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, ... Iowa location. The ... features an ISO 7 cleanroom—the standard needed to compound intravenous (IV) ... level of pollutants. "Our new ... better serve our Iowa patients," said ...
(Date:6/3/2017)... June 3, 2017  Eli Lilly and Company ... results from the Phase 3 MONARCH 2 study ... 6 inhibitor, in combination with fulvestrant, significantly improved ... alone in women with hormone-receptor-positive (HR+), human epidermal ... who have relapsed or progressed after endocrine therapy ...
Breaking Medicine Technology: